Hypothesis: Hospital presentation for acute stroke may have been delayed during COVID-19. We hypothesize that stroke patients with mild symptoms (NIHSS <= 5) were more likely to present in a delayed fashion during the early days of the pandemic. Methods: Get with The Guidelines Stroke registry was used to identify stroke patients that presented between January 1 and August 31, 2020 to the University Hospital in San Antonio, Texas. The cohort was stratified by date of presentation (before COVID: Jan 1 - Mar 15; during COVID: Mar 16 - Aug 31) and presenting NIHSS (<=5 versus >5). We then analyzed by the thrombolytic exclusion criteria delay to arrival and the time interval of stroke symptoms discovery to hospital presentation. Subgroup analysis included age, sex, and ethnicity; race was excluded due to 90% Caucasian cohort. Results: A total of 294 subjects were included of which 115 were before and 179 were during COVID. There were no significant differences in the demographics for these two time periods, although a trend for greater male presentation was seen during COVID (Table 1). After both groups were dichotomized by NIHSS <=5, stroke symptoms discovery to hospital arrival and delay to arrival (Table 2) were not significantly different across subgroups. Conclusions: Regardless of NIHSS, a significant time delay in acute stroke presentation to our hospital was not seen when comparing before and during COVID. Although our study included a large Hispanic population, the cohort was primarily Caucasian; and therefore, the results have limited application. Whether men were more likely than women to present with stroke during COVID is unclear but warrants further study with a larger sample size.
Introduction: An EMS validation study in San Antonio, Texas previously evaluated the Vision Aphasia Neglect (VAN) screen to identify large vessel occlusion (LVO) in the prehospital setting. Because it may be used in the field to bypass hospitals for higher level care, VAN’s performance with stroke mimics, specifically intracerebral hemorrhage (ICH), is important in stroke systems of care. The goal of this study was to determine if a positive VAN assessment correlated with larger ICH. Methods: Paramedics from two San Antonio EMS agencies documented a VAN assessment from June 2017 to April 2019 for all EMS stroke alerts less than 6 hours from last known well. The prehospital VAN score, emergency department advanced neuroimaging interpretation, and hospital discharge diagnosis were collected from three comprehensive stroke centers. Stroke mimics and hemorrhages were included. ICH volume, location, and presence of intraventricular hemorrhage (IVH) were recorded. ICH volume and location were dichotomized by the median value and infratentorial versus supratentorial, respectively. Descriptive statistics were used for continuous data, and categorical data was analyzed by Fisher’s exact test. Results: VAN scores were recorded for 215 EMS activated stroke alerts, of which 131 (60.9%) were VAN positive and 23 (10.7%) were ICH. All were hypertensive etiologies except one arteriovenous malformation related hemorrhage. ICH mean and median values were 15.3 ml and 10.3 ml (range 0.3 - 51 ml), respectively. Of the 23 ICH cases, IVH was present in 7 (30%), and infratentorial location was noted in 4 (17%). Fisher’s exact test for VAN and ICH (categorized as ≥ or < median volume) was significant (0.027, p<0.05). However, VAN versus both ICH location and presence of IVH was non-significant. Conclusion: In this prospective EMS validation study, a pre-hospital VAN positive assessment predicted larger ICH volumes. Although VAN was designed to identify LVO, pre-hospital triage of ICH is an additional benefit of this screening tool. A false positive VAN assessment for LVO may signify a larger ICH, which is often transferred to higher level centers as standard of care. Thus, VAN perform well for both ischemic and hemorrhagic hospital bypass protocols.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.